EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Geraniol alleviates DNCB-induced atopic dermatitis in mice by downregulating IL-4/IL-13 and reducing inflammation

Hafsa Nasr, Arham Shabbir, Rabbia Kalim, Aisha Mobashar, Ali F Almutairy, Hamoud Alotaibi, Saleh Alfuraih, Abdulaziz H Alanazi, Sulaiman Mohammed Abdullah Alnasser, Waad Alrohily, Latifah Al Shammari, Tabinda Fatima und 1 weitere

Biomolecules and Biomedicine · 10.03.2026 · 26 (9) · 1639-1651

DOI: 10.17305/bb.2026.13992 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules and Biomedicine, online erschienen am 10.03.2026. Verfasst von Hafsa Nasr und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Institute of Pharmacy, Faculty of Pharmaceutical and Allied Health Sciences, Lahore College for Women University, Lahore,…. Hauptthemen laut MEDLINE: Acyclic Monoterpenes, Dermatitis, Atopic, Interleukin-4, Interleukin-13. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atopic dermatitis (AD) is a chronic inflammatory skin condition characterized by recurrent itching, predominantly affecting children but also impacting adults. Geraniol, a monoterpene alcohol found in various aromatic plant-based essential oils, possesses a pleasant rose-like scent. This study aimed to investigate the therapeutic potential of geraniol in a mouse model of atopic dermatitis by elucidating its anti-inflammatory and immunomodulatory properties. Mice were subjected to 2% 2,4-Dinitrochlorobenzene (DNCB) to induce AD, and treated with both oral and topical administrations of prednisolone and geraniol from day 7 to day 19. Macroscopic assessments of ear and dorsal skin, as well as ear thickness, were conducted on days 0, 7, and 19. Total leukocyte count (TLC) and differential leukocyte count (DLC) were measured in blood samples using an automatic hematology analyzer. Ear tissues were analyzed for mRNA expression levels of IL-4 and IL-13 via reverse transcription quantitative polymerase chain reaction (RT-qPCR), and molecular docking studies were performed to evaluate the binding affinity of geraniol to these cytokines. Histopathological examination using hematoxylin and eosin staining was conducted on ear and dorsal skin tissues to assess eosinophil and mast cell infiltration, as well as epidermal thickness. The results demonstrated that both oral and topical geraniol significantly alleviated AD-like symptoms. Geraniol treatment led to a reduction in DLC and TLC levels in the blood, as well as downregulation of IL-4 and IL-13 expression in ear tissue. In silico studies revealed that geraniol exhibited moderate binding affinities of -4.5 kcal/mol with IL-4 and -4.9 kcal/mol with IL-13. Histopathological analysis indicated a reduction in epidermal thickness and infiltration of mast cells and eosinophils in geraniol-treated mice. In conclusion, geraniol effectively alleviated atopic dermatitis in mice by reducing clinical scores, inflammatory cell infiltration, epidermal thickening, and regional downregulation of IL-4 and IL-13 mRNA expression. The in silico docking studies support the hypothesis of a potential Th2-modulatory effect of geraniol.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acyclic MonoterpenesDermatitis, AtopicInterleukin-4Interleukin-13DinitrochlorobenzeneAnti-Inflammatory AgentsImmunologic FactorsAdministration, OralAdministration, CutaneousPrednisoloneLeukocyte CountGene Expression RegulationSkinMice, Inbred BALB CMolecular Docking SimulationTh2 CellsMaleAnimalsMiceDisease Models, Animal

Substanzen

geraniolAcyclic MonoterpenesDinitrochlorobenzeneAnti-Inflammatory AgentsImmunologic FactorsPrednisoloneInterleukin-4Interleukin-13Il4 protein, mouseIl13 protein, mouse

Autor:innen und Institutionen

  • Department of Pharmacology, Institute of Pharmacy, Faculty of Pharmaceutical and Allied Health Sciences, Lahore College for Women University, Lahore, Pakistan.
  • Faculty of Pharmacy, The University of Lahore, Lahore, Pakistan.
  • Department of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Buraydah, Saudi Arabia.
  • Department of Pharmaceutics, Faculty of Pharmacy, Northern Border University, Rafha, Saudi Arabia.
  • Department of Pharmacology and Toxicology, College of Pharmacy, Northern Border University, Rafha, Saudi Arabia.
  • Department of Clinical Practice, College of Pharmacy, Northern Border University, Rafha, Saudi Arabia.

Zitieren

APA

Nasr, H., Shabbir, A., Kalim, R., Mobashar, A., Almutairy, A. F., Alotaibi, H., Alfuraih, S., Alanazi, A. H., Abdullah Alnasser, S. M., Alrohily, W., Shammari, L. A., Fatima, T., & Ahmad, A. (2026). Geraniol alleviates DNCB-induced atopic dermatitis in mice by downregulating IL-4/IL-13 and reducing inflammation. Biomolecules and Biomedicine, 26(9), 1639-1651. https://doi.org/10.17305/bb.2026.13992

Vancouver

Nasr H, Shabbir A, Kalim R, Mobashar A, Almutairy AF, Alotaibi H, et al. Geraniol alleviates DNCB-induced atopic dermatitis in mice by downregulating IL-4/IL-13 and reducing inflammation. Biomolecules and Biomedicine. 2026;26(9):1639-1651. doi:10.17305/bb.2026.13992

BibTeX
@article{Nasr2026,
  author = {Nasr, Hafsa and Shabbir, Arham and Kalim, Rabbia and Mobashar, Aisha and Almutairy, Ali F and Alotaibi, Hamoud and Alfuraih, Saleh and Alanazi, Abdulaziz H and Abdullah Alnasser, Sulaiman Mohammed and Alrohily, Waad and Shammari, Latifah Al and Fatima, Tabinda and Ahmad, Ashfaq},
  title = {Geraniol alleviates DNCB-induced atopic dermatitis in mice by downregulating IL-4/IL-13 and reducing inflammation},
  journal = {Biomolecules and Biomedicine},
  year = {2026},
  volume = {26},
  number = {9},
  pages = {1639--1651},
  doi = {10.17305/bb.2026.13992}
}
Kostenlos starten →